Tilray Brands, Inc. (TLRY)
Tilray secures new cannabis cultivation license in Germany: Is it time to buy TLRY?
Tilray Brands Inc (NASDAQ: TLRY) has made a significant stride in its European operations by securing a new cannabis cultivation license in Germany. This development, under the country's new Cannabis Act (MedCanG), is set to substantially boost the production capacity of Tilray's Aphria RX GmbH facility in Berlin.
Is Tilray Brands Stock a Buy?
Acquisitions have been a big part of Tilray's strategy. The company's business is much more diversified than it used to be.
Tilray Brands, Inc. (TLRY) Surpasses Market Returns: Some Facts Worth Knowing
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.93, marking a +1.05% move from the previous day.
Tilray Brands, Inc. (TLRY) Outperforms Broader Market: What You Need to Know
Tilray Brands, Inc. (TLRY) closed at $1.91 in the latest trading session, marking a +1.6% move from the prior day.
Is Tilray's $2B Valuation Just The Beginning? Analyst Sees $10B Market Opportunity, Initiates Coverage
With a $2 billion valuation, Tilray Brands TLRY ranks as the largest cannabis company outside the U.S., leading in international sales and the Canadian recreational market. Pablo Zuanic of Zuanic & Associates has initiated coverage on Tilray with a 'Neutral' rating, highlighting the company's significant potential in global markets.
Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know
Tilray Brands, Inc. (TLRY) closed at $1.66 in the latest trading session, marking no change from the prior day.
Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.69, moving -0.59% from the previous trading session.
Down -8.29% in 4 Weeks, Here's Why Tilray Brands (TLRY) Looks Ripe for a Turnaround
Tilray Brands (TLRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Where Will Tilray Brands Be in 3 Years?
Tilray Brands is a leading cannabis producer in Canada, but its growth prospects depend in large part on whether the U.S. will legalize pot in the near future. But even if that doesn't happen, odds are the business will continue to grow its operations via acquisitions.
1 New Reason to Consider Buying Tilray Brands Stock, and 1 New Reason to Sell
A company in Tilray Brands' marijuana portfolio just went bankrupt. Tilray now needs a new way to get exposure to the U.S. market.
Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
Tilray Brands is raising money through an at-the-market offering. The money is going to be used to fund acquisitions.
Tilray Brands Slashed Its Guidance. Is the Stock a Buy?
Tilray Brands won't be generating more cash than it spends this year. It had previously advised investors to expect the opposite.
